20VPnC

Beating Merck, Pfizer gets priority review as the first Prevnar follow-up heads to the FDA
Endpoints
Wed, 12/9/20 - 10:41 am
Pfizer
20VPnC
Prevnar
pneumococcal disease
Merck
FDA
Pfizer Posts Positive Results in Two Phase III Studies, Postpones Investor Day
BioSpace
Thu, 03/19/20 - 11:12 am
Pfizer
clinical trials
atopic dermatitis
pneumococcal disease
20VPnC
vaccines
abrocitinib
Pfizer posts positive data for 20-strain pneumococcal vaccine
Biopharma Dive
Tue, 04/16/19 - 12:21 pm
Pfizer
vaccines
pneumococcal disease
20VPnC
Pfizer Initiates Ph III Trials for Invasive Pneumococcal Disease and Pneumonia Vaccine
CP Wire
Fri, 12/14/18 - 09:42 am
Pfizer
vaccines
pneumococcal disease
pneumonia
20VPnC
Pfizer Initiates Ph III Trials for Invasive Pneumococcal Disease and Pneumonia Vaccine
Fri, 12/14/18 - 09:10 am
Pfizer
20VPnC
vaccines
pneumococcal disease
pneumonia